Status:
UNKNOWN
Emptying Malaria Reservoirs to Accelerate Malaria Elimination in High Transmission Settings
Lead Sponsor:
Université Catholique de Louvain
Conditions:
Asymptomatic Malaria
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study is a Phase 2 randomized controlled, partial-blind, parallel group study in plasmodium infected asymptomatic adults 18 years and older, with 8 study arms. It will use the adapted Zelen design...
Detailed Description
This study will use the adapted Zelen design which has two steps in the consent process. At step one, informed individuals (students and workers) will be invited to participate in a screening and coho...
Eligibility Criteria
Inclusion
- Be student or worker of a participating University.
- Be 18 years and above, and in good general health condition.
- Have a device (phone, tablet, etc) that will support remote visits.
- Sign written informed consent form.
- Screened positive for malaria (RDT + and qPCR +) but asymptomatic.
Exclusion
- To have a known hypersensitivity to any ingredients of the tea.
- Currently taking a malaria drug for prevention or treatment.
- To have participated in another malaria drug trial or device in the last 14days.
- To have a history or presence of clinically significant medical, psychiatric, or emotional condition.
- Reported diabetic
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT05440773
Start Date
April 1 2023
End Date
February 1 2024
Last Update
July 1 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.